Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis

Overview of attention for article published in Frontiers in Pharmacology, March 2023

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 4 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,539 followers.

RT @FrontPharmacol: New Research: Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer:…

13 Mar 2023

Reply Repost Favourite

New Research: Efficacy and safety of PD-1/PD-L1 inhibitors in the treatment of recurrent and refractory ovarian cancer: A systematic review and a meta-analysis https://t.co/Fgt9qYh1l5 #pharmacology

13 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.